Literature DB >> 17996637

Cognitive/behavioral teratogenetic effects of antiepileptic drugs.

Kimford J Meador1, Gus Baker, Morris J Cohen, Eija Gaily, Michael Westerveld.   

Abstract

The majority of children of mothers with epilepsy are normal, but they are at increased risk for developmental delay. Antiepileptic drugs (AEDs) appear to play a role. Our current knowledge is reviewed, including research design issues and recommendations for future research. In animals, exposure of the immature brain to some AEDs can produce widespread neuronal apoptosis and behavioral deficits. The risks of AEDs in humans are less clear, but recent studies raise concerns, especially for valproate. There is a critical need for well-designed systematic research to improve our understanding of AED effects on the fetal brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996637      PMCID: PMC2713059          DOI: 10.1016/j.yebeh.2007.08.009

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  82 in total

Review 1.  Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction.

Authors:  J E Fisher; C V Vorhees
Journal:  Pharmacol Res       Date:  1992 Oct-Nov       Impact factor: 7.658

2.  Neurodevelopment after in utero exposure to phenytoin and carbamazepine.

Authors:  D W Loring; K J Meador; W O Thompson
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

3.  Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence.

Authors:  J R Farwell; Y J Lee; D G Hirtz; S I Sulzbacher; J H Ellenberg; K B Nelson
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

4.  Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.

Authors:  D Scolnik; I Nulman; J Rovet; D Gladstone; D Czuchta; H A Gardner; R Gladstone; P Ashby; R Weksberg; T Einarson
Journal:  JAMA       Date:  1994-03-09       Impact factor: 56.272

5.  Pattern of malformations in the children of women treated with carbamazepine during pregnancy.

Authors:  K L Jones; R V Lacro; K A Johnson; J Adams
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

6.  Prenatal prediction of risk of the fetal hydantoin syndrome.

Authors:  B A Buehler; D Delimont; M van Waes; R H Finnell
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Dose-response effects of prenatal phenytoin exposure in rats: effects on early locomotion, maze learning, and memory as a function of phenytoin-induced circling behavior.

Authors:  W P Weisenburger; D R Minck; K D Acuff; C V Vorhees
Journal:  Neurotoxicol Teratol       Date:  1990 Mar-Apr       Impact factor: 3.763

Review 8.  Neural and behavioral alterations after early exposure to phenobarbital.

Authors:  J Yanai; F Fares; M Gavish; Z Greenfeld; Y Katz; G Marcovici; C G Pick; Y Rogel-Fuchs; A Weizman
Journal:  Neurotoxicology       Date:  1989       Impact factor: 4.294

9.  Intelligence of children of epileptic mothers.

Authors:  E Gaily; E Kantola-Sorsa; M L Granström
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

10.  The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors.

Authors:  G Lösche; H C Steinhausen; S Koch; H Helge
Journal:  Acta Paediatr       Date:  1994-09       Impact factor: 2.299

View more
  19 in total

1.  Prenatal effects of antiepileptic drugs.

Authors:  Chrysanthy Ikonomidou
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

2.  Effects of breastfeeding in children of women taking antiepileptic drugs.

Authors:  K J Meador; G A Baker; N Browning; J Clayton-Smith; D T Combs-Cantrell; M Cohen; L A Kalayjian; A Kanner; J D Liporace; P B Pennell; M Privitera; D W Loring
Journal:  Neurology       Date:  2010-11-24       Impact factor: 9.910

3.  Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Morris J Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Epilepsy Behav       Date:  2011-05-04       Impact factor: 2.937

Review 4.  Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.

Authors:  Frank M C Besag; Michael J Vasey
Journal:  Paediatr Drugs       Date:  2021-05-06       Impact factor: 3.022

Review 5.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

Authors:  Jakob Christensen; Therese Koops Grønborg; Merete Juul Sørensen; Diana Schendel; Erik Thorlund Parner; Lars Henning Pedersen; Mogens Vestergaard
Journal:  JAMA       Date:  2013-04-24       Impact factor: 56.272

Review 7.  Antiepileptic drugs in women with epilepsy during pregnancy.

Authors:  Evan Gedzelman; Kimford J Meador
Journal:  Ther Adv Drug Saf       Date:  2012-04

8.  A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.

Authors:  Kelly M McVearry; William D Gaillard; John VanMeter; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2009-11-04       Impact factor: 2.937

9.  Folic acid supplementation for women with epilepsy who might become pregnant.

Authors:  Andre H Lagrange
Journal:  Nat Clin Pract Neurol       Date:  2009-01

Review 10.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.